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Abstract
Background: Previous studies have shown that the genus Moraxella is commonly present in the nasal
microbiota of swine.
Results: In this study, 51 isolates of Moraxella were obtained from nasal swabs from 3 to 4 week old piglets,
which represented 26 different fingerprintings by enterobacterial repetitive intergenic consensus (ERIC)-PCR.
Whole 16S rRNA gene sequencing allowed the identification at species level of the Moraxella spp. isolates.
The majority of the field strains were identified as Moraxella pluranimalium, but Moraxella porci was also
detected. In addition, a cluster of 7 strains did not group with any described Moraxella species, probably
representing a new species. Subsequent phenotypic characterization indicated that strains of Moraxella
pluranimalium were mainly sensitive to serum complement, while the cluster representing the putative new
species was highly resistant. Biofilm formation capacity was very variable among the Moraxella spp. isolates,
while adherence to epithelial cell lines was similar among selected strains. Additionally, variability was also
observed in the association of selected strains to porcine alveolar macrophages. Antimicrobial tests evidenced
the existence of multidrug-resistance in the strains.
Conclusions: In summary, phenotypic characterization revealed heterogeneity among Moraxella strains from
the nasal cavity of piglets. Strains with pathogenic potential were detected as well as those that may be
commensal members of the nasal microbiota. However, the role of Moraxella in porcine diseases and health
should be further evaluated.
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Background
Moraxella is a microbiota member of the upper respira-
tory tract in vertebrates, but some species may cause op-
portunistic infections. Best-known Moraxella infections
are produced by Moraxella catarrhalis, which causes
respiratory infections, including pneumonia and otitis in
human [1]. In livestock, Moraxella bovis is well-known as
the etiological agent of infectious keratoconjunctivitis in
cattle [2]. In swine, the genus Moraxella has representative
species, such as Moraxella porci, which was discovered and
isolated from meninges [3] and Moraxella pluranimalium,
described from an abdominal cavity isolate [4], but the
relevance of this genus in swine health is not well estab-
lished. Nonetheless, Moraxella may play a role in swine as a
member of the nasal microbiota, since it has been detected
as one of the most abundant genera in the nasal cavity of
weaned piglets [5], is abundant in the nasal microbiota of
slaughter age pigs [6] and can be found in environmental
samples in farrowing buildings [7].
The microbiota plays an important role in host health
and disease through different mechanisms, such as mat-
uration of the immune system, improvement of the mu-
cosal barrier and resistance against pathogens [8]. In the
case of the nasal microbiota, early colonizers can deter-
mine the stability and composition of bacterial commu-
nity leading to a healthier status, as reported for children
early colonized by high abundance of Moraxella, which
was associated with fewer respiratory infections [9].
However, the specific role of Moraxella, among other
residents of the respiratory microbiota, in health is still
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unknown in pigs. In this study, we performed a geno-
typic and phenotypic characterization of 51 Moraxella
field isolates from the nasal turbinates of weaned piglets.
We assessed their capacity of evasion of the innate
immunity by examining their complement susceptibility
and macrophage association capacity, as well as other
characteristics closely related to its ecological niche,
such as biofilm formation, mucin adhesion and cell ad-
herence. Our results showed genotypic and phenotypic
heterogeneity among the Moraxella isolates.
Results
Bacterial identification and genotyping
Initial identification of bacterial isolates by partial 16S
rRNA gene sequencing showed a total collection of 51
Moraxella spp. isolates. Genotyping by enterobacterial
repetitive intergenic consensus (ERIC)-PCR determined
26 different ERIC fingerprintings, which were not shared
among farms (Table 1). Up to 7 different fingerprinting
profiles were isolated from the same farm, and up to 3
from a single piglet. One isolate of each fingerprinting
(from now on referred as different strains for clarity
throughout the text) were selected for further analysis.
Sequencing of approximately 1360 bp of the 16S rRNA
gene allowed a more precise identification of the Moraxella
isolates. Sequences from the nasal isolates and sequences
from Moraxella sp. type strains from the Ribosomal data-
base were used to build an UPGMA (unweighted pair
group method with arithmetic mean) tree (Fig. 1). Sixteen
nasal strains clustered with more than 99.5% identity with
Moraxella pluranimalium, while one strain, LL-3, was a
bit more divergent, with 99.4% identity. Strain EJ45–1
Table 1 Sampled farms and nasal Moraxella spp. isolated from piglets at weaning (3–4 weeks of age). Ten piglets representing 5
litters from each farm were sampled. Name of strain indicates farm of origin, followed by piglet number and finally the number of
isolate. Exceptions to this are LL and CR isolates, which indicate only the number of isolate
Farm Selected strains Isolates with same ERIC PCR profile Health status Antimicrobial treatmenta
GM GM3–2 GM4–1 Healthy AMOX
GM8–1 –
GM5–1 GM7–2, GM9–1, GM10–1
GM5–5 GM7–6
GM5–7 GM7–8, GM7–9, GM8–4
AR AR-5A AR-5C Healthy AMOX
EJ EJ43-3A – Glässer’s disease ENR
EJ44-2A –
EJ45–1 EJ45–5
UK/LG UK1–12 UK1–32, LG1–4, LG1–6, LG2–2, LG3–7 Healthy –
UK1–20 LG5–5, LG8–3
LG6–2 –
LG6–4 LG6–6
LG6-7 g –
CR CR-18 – Healthy AMOX
CR-10 –
CR-7A CR-12
KD KD4–7 – Healthy –
VL VL6–4 – Healthy TUL, CEFT
VL9–7 VL9–8, VL10–1, VL10–2
VL6–6 –
VL1–4 VL1–7, VL5–3
VL3–9 –
VL2–5 –
VL1–5 VL1–6
LL LL-3 – Nervous signs Unknown
AMOX Amoxicillin, ENR enrofloxacin, CEFT ceftiofur, TUL tulathromycin
aAntibiotics administered before weaning (before sampling)
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clustered with Moraxella porci, with 99.2% identity. Strain
CR-7A showed similarity to M. porci and Moraxella cuni-
culi, but did not clearly cluster with any of them. Finally, a
group of 7 nasal strains showed homology among them of
more than 98%, but did not clustered with any of the
already described Moraxella species, indicating that they
may represent a new species. Biochemical characterization
of representative isolates can be found in Additional file 1.
Antimicrobial susceptibility
Moraxella strains from nasal microbiota showed high
diversity in antibiotic susceptibility (Table 2). In gen-
eral, all the strains were sensitive to amoxicillin+cla-
vulanate and florfenicol, in contrast to trimetoprim +
sulfonamide and tetracycline, where we found a high
resistance rate. Other antimicrobials with low resist-
ance rates were ceftiofur, gentamicin and colistin. Six
strains showed resistance to amoxicillin, which was
abolished with the β-lactamase inhibitor clavulanate.
M. pluranimalium UK1–12 and UK1–20 showed only
resistance to tetracycline; both strains were isolated
from the same farm, which did not use antimicrobials
before the sampling time. Six strains were resistant to
2 different antimicrobials. Multidrug-resistant (MDR),
defined as resistance to 3 or more classes of antimi-
crobials, was found in 18 out of the 26 strains. A
higher percentage of MDR strains was observed in
the farms using antimicrobials than in those not using
these drugs during lactation (75% versus 50%, respect-
ively), although no statistical significance was found.
Fig. 1 UPGMA tree built with the 16S rRNA gene sequences of the Moraxella spp. isolates from the nasal cavities of piglets at weaning. Type
strains (T) of different Moraxella species were included in the analysis
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Serum resistance
Initially, bacterial suspensions were prepared in PBS
obtaining irregular results, due to auto-agglutination by
some strains. To overcome this problem, all the strains
were resuspended in 20% glycerol in PBS and passed
through a needle if necessary; this process did not affect
the viability of the bacteria (not shown).
When the strains were assayed for survival after incu-
bation with fresh rabbit serum, 17 of the 26 (65%)
strains showed a reduction in viability of more than 3
logarithms after incubation with serum (Fig. 2). Within
M. pluranimalium, 12 out of the 16 strains (75%)
showed a reduction of viability of more than 3 logs,
similar to the type strain of this species, while the rest 4
(25%) showed a reduction of 2–3 logs. On the other
hand, only 2 of the 7 (29%) strains from the cluster
representing a putative new Moraxella species showed a
reduction of more than 3 logs in viability, while the rest
of strains in this cluster (5/7; 71%) showed a reduction
of viability of less than 2 logarithms (Fig. 2), indicating
resistance to the serum complement. Moreover, strains
showing the highest resistance to serum were observed
within the isolates from the cluster of the putative new
Moraxella species, and belonged to the same farm
(VL1–4, VL3–9 and VL1–5; Fig. 2). M. porci type strain
SN9-4M, as well as strain M. porci EJ45–1, showed high
susceptibility to the treatment with rabbit sera (Fig. 2).
Biofilm assays
In an attempt to select non-agglutinating variants, we per-
formed several passes of the agglutinating strains UK1–20
and VL6–6 in broth culture. Each passage was performed
with bacteria taken from the surface of the culture that did
not agglutinate. Curiously, a thick biofilm was observed in
the culture tubes of UK1–20 after 27 passes (UK1–20p27);
the bacteria in these cultures did not agglutinate but stuck
to the glass. In the case of VL6–6, a biofilm in the air-
liquid interphase was observed after 27 passes (VL6–6p27)
(Fig. 3). This observation prompted us to examine the nat-
ural level of biofilm formation capacity of the rest of the
nasal Moraxella sp. strains. We found different rates of
biofilm formation that were not dependent on the Morax-
ella species. Observing the results, different levels of bio-
film formation could be arbitrarily established: production
of biofilm when Abs590 ≥ 0.6 and of strong biofilm when
Abs590 > 1.5. With those definitions, strains showing bio-
film production capacity were M. pluranimalium GM3–2,
GM8–1, EJ44-2A, LG6–2,, UK1–20, GM5–1, VL6–4 and
VL9–7; Moraxella sp. LL-3; Moraxella sp. (putative new
species cluster) VL6–6; and also the variants UK1–20p27
and VL6–6p27 used as controls (Fig. 4). Few isolates (M
pluranimalium GM3–2 and LG6–2, and Moraxella sp.
LL-3) were able to form strong biofilms (Fig. 4). In general,
strains forming biofilm under static conditions formed bio-
film also under shaking conditions, although at different
6
5
4
3
2
1
Fig. 2 Serum resistance assay showed diverse CFU reduction among the nasal Moraxella spp. strains. Survival of Moraxella pluranimalium strains
(gray bars), uncertainly classified Moraxella strains (white bars), strains from the putative new Moraxella species cluster (black bars) and M. porci
(streaked bars) was tested with 90% rabbit serum. Initial bacterial inoculum was approximately 106 CFU/ml. Results are expressed as average of
the log CFU reduction after 1 h of incubation at 37 °C with the serum, error bars indicate standard deviation from three replicate assays
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level. Under static conditions, we observed a common
trend of decreasing biofilm production when comparing 24
and 48 h. In contrast, we observed the opposite effect
under shaking conditions, with most of the strains showing
a tendency of increasing biofilm production with time.
Strains with slow growth (unclassified cluster) showed the
same trend in decreasing biofilm production under both
conditions. Biofilm formation was not affected by pre-
coating the wells with mucin or bovine serum albumin
(BSA) (data not shown).
Cell adhesion
To explore whether the biofilm formation was associated
with cell adhesion capacity, selected strains with differ-
ent rates of biofilm formation were assayed in PK-15
and A549 cell lines. Although the assayed strains pre-
sented adhesion ability to cells, the observed differences
in biofilm formation capacity did not correlated with
differences in cell adhesion to both PK-15 (not shown)
or A549 cells (Fig. 5).
Association to porcine alveolar macrophages
Selected strains representing the diversity in phylogen-
etic, serum resistance and biofilm formation were tested
with porcine alveolar macrophages (PAMs). Different
levels of association with PAMs were observed among
the strains (Fig. 6). Within the 4 Moraxella pluranima-
lium strains tested, only LG6–2 presented a clear associ-
ation with PAMS, similar to the level observed in the
susceptible H. parasuis strain used as control. Moraxella
porci EJ45–1, unlike the M. porci type strain SN9-4M,
showed high levels of association with PAMs. The three
isolates from the putative new species cluster presented
low association with macrophages, even lower than the
H. parasuis phagocytosis resistant strain used as control
(Fig. 6). Levels of association to macrophages were not
directly linked to biofilm formation capacity or serum
resistance (Table 3).
In vitro culture passages affected association to
macrophages
In vitro passages affected the autoagglutination and bio-
film formation capacity of M. plurianimalium UK1–20
and Moraxella sp. VL6–6 as indicated above. Although
enhanced adhesion to epithelial cells was not observed
in UK1–20p27 (not shown), this strain showed higher
association with PAMs than the original strain (T test,
P = 0.04; Fig. 6). In contrast, VL6–6p27 showed the same
level of interaction with PAMs as the original strain
VL6–6 (Fig. 6); this may be due to a different adaptation
to laboratory conditions, as observed by the different
type of biofilm formed by this strain.
Discussion
Moraxella spp. from the nasal microbiota of piglets
showed heterogeneous characteristics, from antimicro-
bial resistance profiles to virulent mechanisms and ad-
herence properties. The majority of the isolates belonged
to M. plurianimalium species, but we also detected M.
porci, a couple of isolates of uncertain classification and
a cluster of strains that may constitute a new Moraxella
species. This cluster comprised strains with a slower
growth rate in broth than the rest of the nasal strains
and contained most of the strains with high resistance to
the serum complement.
Higher rates of antimicrobial resistance were found in
strains from farms undergoing antimicrobial treatments,
but further studies are needed to demonstrate that the
administration of these drugs promotes resistance in this
bacterial genus. MDR strains were broadly detected, and
only one strain, UK1–20, from a farm where no antibi-
otics were used, did not show resistance to any of the
Fig. 3 Effect of culture passages on biofilm formation. Biofilm
produced in glass tubes by strains UK1–20 and VL6–6 after 27
culture passages in the laboratory (UK1–20p27 and VL6–6p27). The
original strains are included in the pictures for comparison. Cultures
were incubated for different times (indicated in the figure) and
pictures were taken after elimination of the bacterial culture and
staining with crystal violet. Although it is not clear in the picture,
VL6–6p27 formed biofilm as a floating pellicle at 24 h
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Fig. 4 Biofilm formation by Moraxella spp. isolates. Biofilm formation under static and shaking conditions in microtiter plates for Moraxella spp.
nasal strains. Biofilm was measured at 24 h (open circles) and 48 h (black squares) by staining with crystal violet. In slow growers (cluster of
putative new Moraxella species GM5–5, GM5–7, VL1–4, VL1–5, VL2–5, VL3–9, VL6–6) incubations were 48 h and 72 h (open circles and black
squares, respectively). Quantification of biofilm was determined the absorbance at 590 nm of the dissolved dye. Strains UK1–20 and VL6–6 after
27 in vitro culture passages (UK1–20p27 and VL6–6p27) were included in the assay. Blank wells with uninoculated medium were also processed
and included in the figure. Vertical dashed lines indicate the levels used in this study to consider that a strain had ability to form biofilm
(Abs590≥ 0.6) or strong biofilm (Abs590 > 1.5)
Fig. 5 Bacteria adhesion to A549 cells. Two biofilm forming strains, LG6–2 and UK1–20p27, and two non-forming strains, LG6-7 g and SN9-4 M,
were incubated with pulmonary A549 cells to examine their adhesion capacity. After 1 h of incubation, non-attached bacteria were washed and
attached bacteria were quantify by dilutions and plating. Results represent the average adherent bacteria from 3 different assays (error bars:
standard deviation)
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antimicrobials tested. It is important to highlight the
presence of four MDR strains of Moraxella pluranima-
lium, with a high number of drug resistances, including
colistin in two of them. This latter observation is
consistent with the recent discovery of colistin resistance
genes in Moraxella [10–12]. Coding genes of antibiotic
resistances can be horizontally transferred between bac-
teria of the same or even different species, and therefore,
the presence of resistance genes in the resident micro-
biota is of concern since they could be transferred to
potential pathogens [13]. Diversity of the nasal Morax-
ella isolates was also evident in the in vitro assays, where
strains showed a wide heterogeneity.
Biofilms are traditionally considered forms of resistance
to environmental conditions and a virulence mechanism
in bacteria of clinical importance [14]. As for other char-
acteristics, we observed heterogeneity in biofilm formation
capacity of the porcine nasal strains of Moraxella. Vari-
ability in biofilm formation has been already reported for
other species of Moraxella from ruminants [15]. Biofilm
formation capacity can be associated also to the col-
onizing ability of the bacteria, as was observed for H.
parasuis [16]. The interaction of the nasal Moraxella
strains with the respiratory mucosa needs more study,
but attachment to mucin as wells as to epithelial cells
could play a role, as suggested by our results.
Fig. 6 Phagocytosis susceptibility of selected Moraxella spp. strains. Selected M. pluranimalium strains (gray bars), strains from the putative new
species cluster (black bars) and M. porci strains (streaked bars). FITC-labelled Moraxella spp. strains were incubated with porcine alveolar
macrophages (PAMs) during 1 h at 37 °C. After washing to eliminate unbound bacteria, association of bacteria with PAMs was measured by flow
cytometry and expressed as % of fluorescent PAMs. H. parasuis susceptible strain SW114 and resistant strain Nagasaki were included as control for
the assay (white bars) and SW114 levels of phagocytosis were used to normalize the results of different tests. In addition, strains UK1–20 and
VL6–6 after 27 passages on agar plates were also tested (dotted bars). Results represent the average of duplicate wells from 2 different assays
(error bars: standard deviation)
Table 3 Summary of results from serum susceptibility,
association to alveolar macrophages and biofilm formation
capacity for selected Moraxella spp. Isolates
Strains Biofilm formationb Serum susceptibilityc Association to
macrophages
M. pluranimalium
LG6–2 + S S
UK1–20 + S R
LG6-7 g – S R
VL6–4 + S R
Moraxella sp.a
VL6–6 + S R
VL1–4 – R R
VL1–5 – R R
M. porci
EJ45–1 – S S
SN9-4 M – S R
aStrains in the putative new Moraxella species cluster
bAbs590 > 0.8 in the crystal violet assay
cViability reduction of more than 3 logarithms
López-Serrano et al. BMC Veterinary Research           (2020) 16:28 Page 8 of 12
On the other hand, bacteria from the upper respiratory
tract can occasionally reach the lower tract, where they
will be confronted with other components of the im-
mune system, such as the alveolar macrophages. In vitro
assays with PAMs provided insight into the potential of
the nasal isolates to survive this first barrier of cell im-
munity in the lung. Heterogeneity in this feature has
been shown for other bacterial species, such as H. para-
suis [17] or Klebsiella pneumoniae [18]. In our case,
strains with high association to PAMs, such as LG6–2,
were observed, while other strains did not associate with
the phagocytic cells, as the case of the virulent SN9-4M.
According to the results, macrophage association is not
directly associated with the phylogeny of the isolates,
since heterogeneity in this trait was observed within the
distinct species or clusters. One paradigmatic case could
be EJ45–1 and SN9-4M from M. porci, having high differ-
ences between them. The importance that phagocytosis
resistance could have for in vivo infection/colonization by
M. pluranimalium is supported by the fact that originally
the UK1–20 strain showed no association with PAMs
(indicative of resistance to phagocytosis), but lost this trait
after in vitro culture passages, in agreement with the loss
of virulence after laboratory adaptation in other bacteria
[19]. Loss of phagocytosis resistance in UK1–20 was
concurrent with increase biofilm formation capacity.
Thus, biofilm formation may be relevant in environmental
persistence, whereas phagocytosis resistance will be im-
portant during host infection. However, this phenomenon
seems to be strain-dependent, since it was not observed
with strain VL6–6, which did not show an adaptation to
laboratory conditions that affected its original resistance
to PAMs.
Most of the assayed Moraxella spp. strains showed sen-
sitivity to the serum complement, with some exceptions,
including most of the strains in the cluster representing a
putative new species. Thus, most nasal Moraxella strains
are probably poorly invasive and will be kept on the nasal
mucosa, but the new putative species cluster deserves
more attention to define their role in disease in pigs.
Conclusions
The characterization of Moraxella spp. isolates from the
nasal cavities of young piglets demonstrated a high het-
erogeneity within this genus. Most of the isolates were
identified as M. pluranimalium, and only one as M.
porci. A group of 7 isolates clustered together by 16S
rRNA gene sequence and did not show homology to any
known Moraxella species. Many of the Moraxella spp.
strains were resistant to multiple antimicrobial classes.
Heterogeneity of the Moraxella strains was also evident
in adhesion and virulence-associated assays. Further ana-
lyses, including experimental infections, need to be done
to explain the function of this genus in swine health and
disease.
Methods
Isolation and bacteria cultures
Nasal cavities from 10 piglets of around 3 weeks of age
from 5 different litters were sampled from 8 commercial
farms (Table 1) with standard management practices for
husbandry and welfare of the animals. Sampling of
piglets was done under institutional authorization and
followed good veterinary practices. According to European
(Directive 2010/63/EU of the European Parliament and of
the Council of 22 September 2010 on the protection of
animals used for scientific purposes) and Spanish (Real
Decreto 53/2013) normative, this procedure did not require
specific approval by an Ethical Committee. Nasal sampling
was performed only once to each piglet and is not likely to
cause pain, suffering, distress or lasting harm equivalent to,
or higher than, that caused by the introduction of a needle
in accordance with good veterinary practice (Chapter I,
Article 1, 5 (f) of 2010/63/EU). Nasal swabs were trans-
ported in Amies medium to the laboratory, where they
were plated on chocolate agar (Biomérieux, Marcy l’Étoile,
France) to isolate colonies. After 24 and 48 h of incubation
at 37 °C and 5% CO2, different colonies were selected and
stored at − 80 °C in 20% glycerol-Brain Heart Infusion
broth (BHI) for further characterization. Bacterial suspen-
sions were also performed in phosphate-buffered saline
(PBS) for DNA extraction.
In addition, reference strains of Moraxella porci SN9-
4M and Moraxella pluranimalium CD12-CA4, both
isolated from lesions of diseased pigs, were used in this
study. For assays with PAMs, 2 reference strains of Hae-
mophilus parasuis were used as controls.
Bacterial identification and genotyping
DNA extraction was performed using Chelex based Insta-
gene™ Matrix (Bio-Rad Laboratories, Hercules, CA, USA)
following manufacturer’s instructions. Preliminary identifica-
tion of isolates was performed by partial sequencing of the
16S rRNA gene using primers 358F (CTACGGGAGGCAG-
CAGT) and 907R (CCGTCWATTCMTTTGAGTTT) [20].
Sequences were analyzed by blasting against the Ribosomal
database (http://rdp.cme.msu.edu).
All isolates identified as Moraxella were then genotyped
by ERIC-PCR [21] with primers ERIC-1F (ATGTAAGCTC
CTGGGGATTCAC) and ERIC-2R (AAGTAAGTGACTG
GGGTGAGCG). PCR reaction mixture consisted of 3mM
of MgCl2, 1.2 μM of each primer, 0.23mM of dNTPs, 0.75
U of GoTaq® polymerase (Promega, Madison Wisconsin,
USA) and 100 ng of DNA sample. Amplification was carried
out with an initial denaturation of 94 °C for 2min followed
by 30 cycles of 30 s at 94 °C, 1min at 50 °C and 2.5min at
72 °C, and a final extension of 20min at 72 °C. One isolate
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from each fingerprinting profile was selected for further
analysis.
Final identification of the different Moraxella strains was
performed by 16S rRNA gene amplification with universal
primers 8F (AGAGTTTGATCCTGGCTCAG) and 1492R
(CGGTTACCTTGTTACGACTT) [22] and sequencing
with 8F, 1492R, 358F and 907R primers. Sequence analysis
was performed with Fingerprinting II v3.0 software (Bio-
Rad) and a UPGMA dendrogram was built for species
assignment, including sequences from different Moraxella
spp. type strains. Biochemical characterization of represen-
tative isolates was performed using the Vitek 2 system
(Biomerieux).
Antimicrobial susceptibility
Susceptibility to several antimicrobials was tested as pre-
viously described [23]. Neo-Sensitabs™ diffusion tablets
(Rosco Diagnostica, Taastrup, Denmark) were used for
Gentamicin, Ceftiofur, Colistin, Erythromycin, Lincoe-
spectin, Tetracycline, Doxycycline, Trimetoprim + Sulfa-
mide (T + S), Enrofloxacin, Amoxicillin and Amoxicillin
+ Clavulanic acid testing. Marbofloxacin, florfenicol and
tulathromycin were tested in chocolate agar plates at dif-
ferent dilutions, from 16 to 0.125 μg/mL in the case of
florfenicol and marbofloxacin; and from 64 to 0.125 μg/
mL in the case of tulathromycin. McFarland suspensions
of 0.5 in 0.9% NaCl were prepared for each strain and
streaked on the plates with the different antibiotic con-
centration. Minimal inhibitory concentration (MIC) was
determined observing the bacterial growth after 24 h of
incubation. As no clinical breakpoints are available for
these species, available CLSI breakpoints for Moraxella
catarrhalis were taken for Tetracycline, Doxycycline,
Trimetoprim+Sulfonamide, and veterinary practice ac-
cording to CLSI breakpoints was followed for the rest of
drugs (EUCAST-and CLSI potency NEO-SENSITABS,
Rosco Diagnostica, 2013).
Serum resistance assay
Serum resistance assay was carried out with rabbit
serum (EU Directive 2010/63/EU and Spanish normative
Real Decreto 53/2013 were followed). A bacterial sus-
pension of each strain (representative of each ERIC fin-
gerprinting) was prepared in PBS with 20% glycerol to
reach an OD600 of 0.3 in a VIS 7200 spectrophotometer
(Dinko Instruments, Barcelona, Spain). In duplicate
wells, 10 μl of the bacterial suspension (approx. 106 col-
ony forming units [CFU]/mL) were mixed with 90 ul of
fresh filtered rabbit serum and mixtures were incubated
for 1 h at 37 °C and 100 rpm. Bacterial survival was cal-
culated by comparing bacterial counts (obtained by serial
dilutions and plating) at time 0 and after 1 h incubation.
The assay was carried out 3 times for each strain.
Association to porcine alveolar macrophages
Association to macrophages was tested as previously
described with PAMs [17]. PAMs were obtained from
healthy piglets euthanized by intravenous pentobarbital
overdose under institutional authorization. All proce-
dures involving animals followed EU and Spanish nor-
mative (Directive 2010/63/EU and Real Decreto 53/
2013). Lungs were removed and PAMs were isolated by
lung lavage with PBS containing 70 μg/mL of gentami-
cin. PAMs were collected by centrifugation at 241 x g
for 15 min, washed twice with sterile PBS and stored at
− 150 °C in 10% Dimethylsulfoxide (DMSO) in fetal bo-
vine serum (FBS) until use.
Selected nasal strains of Moraxella were tested to de-
termine their level of association to PAMs. Moraxella
porci reference strain SN9-4M was also included in the
assay. In addition of two reference strains of Haemophi-
lus parasuis, Nagasaki (virulent) and SW-114 (non-viru-
lent), were included as control for the technique.
For the assay, PAMs were plated in Dulbecco’s Modi-
fied Eagle Medium (DMEM) supplemented with 10% of
FBS and 1% glutamine at a concentration of 5 × 105 cells
per well in 6 well-plates. Plates were incubated 1–2 h to
allow the attachment of the macrophages to the bottom
of the wells. For each strain duplicate wells were inocu-
lated with 107 CFU of fluorescein isothiocyanate (FITC)-
labelled bacteria (bacterial inocula were confirmed by
dilutions and plating). After 1 h of incubation at 37 °C
and 5% CO2, plates were transferred to an ice bath to
stop interaction and were washed twice with PBS to
eliminate unbound bacteria. PAMs were then scrapped
in PBS and were analyzed by flow cytometry using an
EPICS XL-MCLTM Flow Cytometer (Beckman Coulter,
Madrid, Spain) or MACSQuant Analyzer 10 (Myltenyi
Biotec, Bergisch Gladbach, Germany). Assays were
repeated with PAMs from different animals that were
already available at the laboratory. Since each batch of
macrophages showed different level of activity, values
were harmonized considering the reference H. parasuis
strain SW114 (phagocytosis sensitive) as 100% phagocyt-
osis in each assay; i.e., using the following calculation: (%
PAMs with test bacteria - % fluorescence background in
PAMs without bacteria / % PAMs with positive control
SW114 - % fluorescence background in PAMs without
bacteria) × 100.
Biofilm assays
Biofilm assays were performed in 96 well cell culture
plates under static and shaking conditions following
previous published protocol with some modifications
(Bello-Ortí et al. 2014). Bacterial suspensions were made
to reach an OD600 0.3 in BHI. Wells in 96 well plates
were then inoculated in quadruplicate with a 1:100 dilu-
tion of the bacterial suspension in BHI. Plates were
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incubated at 37 °C, under static conditions with 5% CO2
or under agitation at 100 rpm for 24 and 48 h, except for
slow growing isolates, which were incubated for 48 and
72 h. After incubation, wells were emptied and rinsed
with tap water to remove unattached bacteria. Wells
were then stained with 0.1% (w/v) crystal violet (Merck,
Darmstadt, Germany) for 2 min at room temperature.
Wells were washed thrice with tap water to remove the
excess of crystal violet and let dried at 37 °C. The dye in
the stained biofilms was solubilized with 100 μL of 70%
ethanol and quantified at 590 nm in a Powerwave XS
Microplate Spectrophotometer (Biotek Instruments Inc.,
Winooski, VT, USA). Biofilm formation was also
assessed on wells pre-coated with 5 μg of mucin or BSA
as control.
Cell adhesion assay
Porcine epithelial cells PK-15 (ATCC® CCL-33) and hu-
man lung A549 (ATCC® CCL-185) cell lines were cultured
in DMEM supplemented with 1% glutamine and 5% FBS
for PK-15 and 10% for A549 cells.
Concentration of cells per ml was calculated to obtain
a monolayer after overnight incubation, approximately
50,000 cells/well in cell culture 96 well plates. After
overnight incubation, wells with PK-15 or A549 cells
were washed once with sterile PBS. Duplicate wells were
inoculated with 107 CFU/mL bacteria from each isolate
tested. Bacterial inoculum quantification was confirmed
by colony counts. Microplates were then centrifuged 10
min at 100 x g to facilitate the contact between bacteria
and cells. After incubation for 1 h at 37 °C and 5% CO2,
wells were washed twice with sterile PBS to remove un-
attached bacteria, and attached bacteria were released with
0.1% of saponin and pipetting. The resulting suspension
was quantified by plating dilutions on agar plates.
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